Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Temporary ovarian suppression with hormone analogue may preserve fertility...

Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )

Two years of extended anastrozole therapy as effective as five

Prof Michael Gnant - Medizinischen Universität Wien, Vienna, Austria

Two years of extended anastrozole therapy as effective as five ( Prof Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )

Tandem duplicator phenotypes define 50% of triple negative breast cancers

Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA

Tandem duplicator phenotypes define 50% of triple negative breast cancers ( Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA )

Updated genomic screening tool for life-time breast cancer risk

Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake...

Updated genomic screening tool for life-time breast cancer risk ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )

Temporary ovarian suppression with hormone analogue may preserve fertility...

Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )

Acupuncture significantly reduces joint pain for breast cancer patients

Prof Dawn Hershman - Columbia University Medical Center, New York, NY

Acupuncture significantly reduces joint pain for breast cancer patients ( Prof Dawn Hershman - Columbia University Medical Center, New York, NY )

Immunotherapy shows early promise for patients with trastuzumab-resistant...

Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

Immunotherapy shows early promise for patients with trastuzumab-resistant breast cancer ( Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

HR–positive advanced breast cancer: Ribociclib improved PFS for pre and...

Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA

HR–positive advanced breast cancer: Ribociclib improved PFS for pre and perimenopausal women ( Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA )

HER2low invasive breast cancer: Trastuzumab offers no improvement for invasive...

Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California...

HER2low invasive breast cancer: Trastuzumab offers no improvement for invasive disease free survival ( Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California, USA )

Adjuvant trastuzumab did not improve outcomes for patients with HER2-low breast...

Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California...

Adjuvant trastuzumab did not improve outcomes for patients with HER2-low breast cancer ( Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California, USA )

Increasing the dose intensity of chemotherapy may lower the risk of breast...

Prof Richard Gray - University of Oxford, Oxford, UK

Increasing the dose intensity of chemotherapy may lower the risk of breast cancer recurrence and death ( Prof Richard Gray - University of Oxford, Oxford, UK )

The importance of data connectivity and e-health

Dr Stephen Robbins - Institute of Cancer Research, University of Calgary...

The importance of data connectivity and e-health ( Dr Stephen Robbins - Institute of Cancer Research, University of Calgary, Calgary, Canada )

More from ecancer